Rhone-Poulenc Nutrition Animale – Trademark Portfolio
Entity Type: 03
Rhone-Poulenc Nutrition Animale holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 31 (Natural Agricultural Products) — 11 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ROVABIO and RHODIMET. The owner is based in Commentry.
Rue Marcel Lingot
Commentry 03600 , FR
Showing of trademarks Trademarks
Trademark Classifications
Rhone-Poulenc Nutrition Animale's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Rhone-Poulenc Nutrition Animale have?
Rhone-Poulenc Nutrition Animale has 15 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 abandoned, 9 cancelled.
What trademark classes does Rhone-Poulenc Nutrition Animale file in?
Rhone-Poulenc Nutrition Animale files trademarks across 3 Nice Classification classes. The most active classes are Class 31 (Natural Agricultural Products), Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 31 covers raw and unprocessed agricultural, aquacultural, horticultural and forestry products.
What are Rhone-Poulenc Nutrition Animale's most well-known trademarks?
Rhone-Poulenc Nutrition Animale's registered trademark portfolio includes well-known marks such as ROVABIO and RHODIMET. These are among 2 currently registered trademarks in the portfolio.
What is Rhone-Poulenc Nutrition Animale's trademark registration success rate?
Rhone-Poulenc Nutrition Animale has a 13% trademark registration rate, with 2 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.